Close

Abbott (ABT) Blood and Plasma Screening System Alinity Gains CE Mark

January 10, 2017 7:07 AM EST Send to a Friend
Abbott (NYSE: ABT) announced today its Alinity™ s System for blood and plasma screening received CE Mark and is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login